Loughborough University
Leicestershire, UK
LE11 3TU
+44 (0)1509 263171
Loughborough University

School of Sport, Exercise and Health Sciences

Applied Cognitive Research

Applied Cognitive Research (ACR)

ACR Home | Our Research | Selected Publications
People in the Group | News | Contact Us
See also: Centre for Global Health & Human Development

 

Selected Publications

 

Scientific publications in international journals

  1. Hogervorst, E., Yaffe, K., Richards, M., Huppert, F.A. (2009) Hormone replacement therapy to maintain cognitive function in women with dementia-update. Cochrane-Database-Syst-Rev. 2009; (2): CD003799. 100

  2. Chapelain AS, Hogervorst E, Hand preferences for bimanual coordination in 29 bonobos (Pan paniscus), Behavioural Brain Research (2009), Jan 3;196(1):15-29.

  3. Kalaria, RN. et al (including Hogervorst E. for the World Federation of Neurology Dementia Research Group) Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurology 2008 (IF 10.2 in 2007)

  4. Hogervorst, E., Huppert, F, Matthews, F, Brayne, C (2008). Thyroid function and cognitive decline in the MRC Cognitive Function & Ageing Study. Psychoneuroendocrinology Aug;33(7):1013-22. Epub 2008 Jul 21 (IF 4.85 in 2006)

  5. Hogervorst, E, Sadjimin, T, Yesufu, A., Rahardjo, T. 2008. High tofu intake is associated with worse memory in Indonesian elderly men and women Dementia: 26:50-57 (IF 2.51 in 2006)

  6. Rodrigues MA, Verdile G, Foster JK, Hogervorst E, Joesbury K, Dhaliwal S, Corder EH, Laws SM, Hone E, Prince R, Devine A, Mehta P, Beilby J, Atwood CS, Martins RN.Gonadotropins and Cognition in Older Women. J Alzheimers Dis. 2008 Apr;13(3):267-274. (IF 3.06)

  7. Hogervorst, E. (2008). Commentary on Emmelot Vonk Testosterone supplementation did not prevent cognitive decline or increase bone mineral density in older men JAMA 2008; 299:39-52. American College of Physicians Journal Club, vol 148 (3) May, JC3-4

  8. Lethaby, A, Hogervorst, E., Richards, M., Yesufu, A., Yaffe, K. (2008) Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane review update Jan 23;(1):CD003122.

  9. Hogervorst, E. (2008). Commentary on Emmelot Vonk Testosterone supplementation did not prevent cognitive decline or increase bone mineral density in older men JAMA 2008; 299:39-52. Evidence-Based Medicine, 8113, May

  10. Hogervorst, E. Bandelow S., Oliveira, M. Schmitt JAJ, Gleeson, M. (2008) Caffeine, cognition and sports performance. Med Sci Sports Med, Oct, 40(10):1841-1851. (IF 2.91)

  11. Hogervorst, E & Bandelow S (2007) Should surgically menopausal women be treated with estrogens to decrease the risk for dementia? Invited Editorial Neurology 69, pp. (IF 5.97)

  12. Yesufu., A., Bandelow, S., Hogervorst, E. (2007) Meta-analyses of the effect of hormone treatment on cognitive function in postmenopausal women. Women’s health invited review. p 173-195

  13. Bandelow, S, Hogervorst, E. (2006) Improving the diagnosis of early dementia using computerized validated systems. Invited editorial JEAAM, 3, 7-9

  14. Schrijnemaeckers, A.M.C., De Jager, C.A., Hogervorst, E., Budge, M.M. (2006). Cases with Mild Cognitive Impairment and Alzheimer’s disease fail to benefit from repeated exposure to episodic memory tests as compared with controls J Clin Exp Neuropsychol. 2006 Apr;28(3):438-55.(IF 1.27)

  15. Hogervorst, E., Bandelow, S., Moffat, S.D. (2005). Increasing testosterone levels and effects on cognitive function in elderly men and wonen: a review. Current Drug Targets-CNS and Neurol Disorders, 4, 531-40 (IF 4.38)

  16. Hogervorst, E., Bandelow, S., Hart, J., Henderson, V.W. (2004d). Two parallel versions of the TICS-m tested in a rural aging population. Int J Geriatric Psychiatry 19: 1-6 (IF 1.93)

  17. Hogervorst, E., Bandelow, S., Combrinck, M, Smith, A.D. (2004c). Low free testosterone is an independent risk factor in AD. Exp Gerontol. Nov-Dec;39(11-12):1633-9. (IF 3.008)

  18. Hogervorst, E. & Bandelow, S. (2004b). The controversy over levels of sex steroids in cases with Alzheimer’s disease. J. Neuroendocrinology, 16(2):93-4 (IF 2.99)

  19. Hogervorst, E., deJager, C., Budge, M., & Smith, A.D. (2004a). Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women Psychoneuroendocrinology Volume 29, Issue 3, April 2004, Pages 405-421 (IF 4.38)

  20. Burnham, H., Hogervorst, E. (2004). Facial recognition in AD. Dementia; 18(1): 75-79 (IF 1.74)

  21. VanBoxtel, M.P.J., Menheere, P., Bekers, O., Hogervorst, E., & Jolles, J. (2004). Thyroid function, depressed mood and verbal memory in older individuals: the Maastricht Aging Study. Psychoneuroendocrinology, Aug;29(7):891-8. (IF 4.38)

  22. VanOs, L., Hogervorst, E., Combrinck, M., Smith, A.D. (2004). Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease. Neurology; Jun 8;62(11):1967-71.

  23. Lehmann, D. J., Hogervorst, E., Warden, D.R., Butler, H.T., Ragoussis, J., Smith, A.D. (2004) The androgen receptor CAG repeat and serum testosterone in the risk of AD in men. JNNP,vol 75(1):163-4 (IF 3.63)

  24. Henderson, V. & Hogervorst, E. (2004). Invited Editorial Testosterone levels in AD: is it men’s turn now ?. Neurology, 62(2):170-171

  25. Hogervorst, E. (2003d). INVITED COMMENTARY to 'Estrogen Plus Progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women' and 'Effect of estrogen plus progestin on global cognitive function in postmenopausal women'; JAMA May 28, 289 (20). Evidence based Gynaecology & Obstetrics. Volume 5, Issue 4 , December 2003, Pages 189-191

  26. Hogervorst, E., Combrinck, M., & Smith, A.D. (2003c). Testosterone and gonadotropin levels in men with AD. Neuroendocrinology Letters, Jun-Aug;24(3-4):203-8. (IF 0.77)

  27. Hogervorst, E. Bandelow, S., Combrinck, M. Irani, S.. & Smith, A.D. (2003b). The validity and reliability of 6 sets of clinical criteria to classify Alzheimer's disease and vascular dementia in post-mortem confirmed cases: added value of a decision- tree approach. Dementia;16(3):170-180

  28. Hogervorst, E., Williams, J., Combrinck, M., Smith, A.D. (2003a). High levels of serum estradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method. Eur J Clin Endo, Jan 148, 67-72

  29. Schmitt, J.A.J., Hogervorst, E.,Vuurman, E. F.P.M., Jolles, J., Riedel., W.J. (2003) Memory functions and focussed attention in middle-aged and elderly subjects are unaffected by a low, acute dose of caffeine. J Nutr Health Aging, 7(5):301-3.

  30. DeJager, C.A., Hogervorst, E., Combrinck, M., Budge, M.M. (2003) Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease. Psychol Med. Aug;33(6):1039-50.

  31. Riedel, W.J., Jorissen, B.L., Hogervorst. E. (2003). Nutritional manipulations and psychiatric conditions: focus on mood and cognition. Acta Neuropsychiatrica;15: 4-7.

  32. Lehmann, D.J., Butler, H.T., Warden, D.R., Combrinck, M., Nicoll, J.A.R., de Jager, C.A., Hogervorst, E., Esiri, M.M., Ragoussis, J., Smith, A.D. (2003). Association of the androgen receptor CAG repeat polymorphism with Alzheimer disease in men. Neurosci Lett; 340(2)87-90.

  33. Maki, P.& Hogervorst, E. (2003) Hormone replacement therapy and cognitive decline. Bailleire's Best Practice & Research Clin End & Metab;17(1): 105-122

  34. Hogervorst, E., Lehmann, D.J., Warden, D.R., McBroom, J., Smith, A.D. (2002f). Apolipoprotein E ε4 and testosterone interact in the risk of Alzheimer’s disease in men. Int J Geriatr Psychiatry, 17, 938-940

  35. Hogervorst, E., Yaffe, K., Richards, M., Huppert, F.A. (2002e) Hormone replacement therapy to maintain cognitive function in women with dementia. Cochrane-Database-Syst-Rev. 2002; (3): CD003799. 100

  36. Hogervorst, E., Yaffe, K., Richards, M., Huppert, F.A. (2002d) Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane-Database-Syst-Rev. 2002:CD003122

  37. Hogervorst, E. & Smith, A.D. (2002c). The interaction of serum folate and estradiol levels in Alzheimer's disease. Neuroendocrinology Letters, April 23(2) 67-72.

  38. Hogervorst, E., Mendes Ribeiro, H., Molyneux, A., Budge, M., Smith A.D. (2002b). Serum homocysteine, cerebrovascular risk factors and white matter low attenuation on CT scans in patients with post-mortem confirmed AD. Arch Neurology, May 59: 787-793. IF 4.68

  39. Hogervorst, Eva, Marc Combrinck Pablo Lapuerta, Judith Rue Kate Swales Marc Budge (2002a). The Hopkins Verbal Learning Test and screening for dementia. Dement Geriatr Cogn Disord; Dec 2001 13:13-20.

  40. Budge, M., De Jaeger, C., Hogervorst, E., & Smith, A.D. (2002). Total plasma homocysteine, age, systolic blood pressure and cognitive performance in the elderly. JAGS; 50;2014-2018

  41. Hogervorst, E., Williams, J.W., Budge, M., Barnetson, L., Smith, A.D. (2001). Serum total testosterone is lower in men with Alzheimer’s disease. Neuroendocrinology Letters, 22, 163-168.

  42. Mendes Ribeiro H.K., Barnetson, L.P., Hogervorst, E., Molyneux, A. (2001) A new visual rating scale for white matter low attenuation on CT. Eur Neurol; 45 (3)140-4.

  43. Hogervorst, E., Williams, J.W., Budge, M., Riedel, W.J., Jolles, J. (2000c). The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analyses. Neuroscience, 101 (3), 485-512.

  44. Hogervorst, E. & McShane, R. (2000b). Editorial on Mulnard RA et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomised controlled trial. JAMA 2000 Feb 23; 283: 1007-15 In Evidence-Based Mental Health, 3, 83.

  45. Hogervorst, E. Barnetson, L., Jobst, K.J., Combrinck, M., Nagy, Zs., & Smith, A.D. (2000a) Diagnosing dementia: interrater-reliability assessment and accuracy of the NINCDS/ARDA criteria versus CERAD histopathological criteria for Alzheimer’s Disease. Dement Geriatr Cogn Disord; 11 (2):107-113

  46. Budge, M., Johnston, C., Hogervorst, E., De Jaeger, C., Milwain, S., Iversen, S., Barnetson, L., King, E., & Smith, A.D. (2000). Plasma total homocysteine levels and cognitive performance in a volunteer elderly population. R.N. Kalaria & P. Ince (Eds.). Vascular Factors in Alzheimer’s Disease. NY Ac Sci,: NY. Annals of the New York Academy of Sciences. 903; 407-411.

  47. Hameleers, P.A.H.M., vanBoxtel, M.P.J., Hogervorst, E., Houx, P.J., Bunxtinx, F., Riedel, W.J., Jolles, J. (2000) Habitual caffeine consumption is associated with improved long term memory performance and simple response speed across multiple age groups. Human Psychopharmacology, 15. 573-581

  48. Schmitt, J.A.J., Jorissen, B., Sbjozcak, S., vanBoxtel, M.P.J., Hogervorst, E., Deutz, N., & Riedel, W. (2000). Tryptophan depletion impairs memory consolidation but improves focused attenuation in healthy young volunteers. Journal of Psychopharmacology. 14(1); 21-29.

  49. Hogervorst, E., Riedel, W., Boshuisen, M.L., & Jolles, J. (1999b) The effects of HRT on cognitive functions in elderly women. Psychoneuroendocrinology, 24(1):43-68

  50. Hogervorst, E., Riedel, W., Kovacs, E., Brouns, F., & Jolles, J. (1999a). Caffeine improves cognitive performance after strenuous physical exercise. Int J Sports Medic, 20 (6), 354-361 (1.23)

  51. Hogervorst, E., Riedel, W., Schmitt, J., & Jolles, J. (1998). Caffeine enhances memory performance during distraction in middle-aged but not in young or old subjects. Human Psychopharm, 13, 277-284

  52. Hogervorst, E., Riedel, W.J., Jeukendrup, A., & Jolles, J. (1996) Cognitive performance after strenuous exercise. Perceptual and Motor Skills, 83 (2), 479-488.

  53. Riedel, W.J., Hogervorst, E., Leboux, R.L.A.M., Verhey, F.J., Van Praag, H.M., Jolles, J. (1995). Caffeine attenuates scopolamine-induced memory impairment in humans. Psychopharmacology, 122 (2), 158-168.

  54. Merckelbach, H., Hogervorst, E., Kampman, M., & De Jongh, A. (1994). Effects of 'eye movement desensitisation' on emotional processing in normal subjects. Behavioral and Cognitive Psychotherapy, 22 (4), 331-335.

  55. Hogervorst, E., Riedel, W.J., Schmitt, J.A.J., Houx, P.J., & Jolles, J. (in revision) The effect of age, health, and speed of information processing on complex memory performance. Journals of Gerontology.

 

Annotations / Abstracts

  1. Hogervorst, E. HRT and Cognition: is testosterone an alternative ? American Aging Association, 28 May-1 June 2009 Scottsdale Arizona Yale Hotel, USA Invited keynote speaker

  2. Hogervorst, E. HRT and Cognition. Invited speaker EMAS London, 16-19 May 2009

  3. Hogervorst, E. Testosterone, cognitive function and AD. Testosterone and men's health. 1 Nov, 2009 Royal College of Physicians Dublin, Ireland

  4. Hogervorst, E. Caffeine and sport performance. Psychobiology meeting Lake district Ambleside Low wood hotel Lake District UK 6-9 September 2008 (invited keynote lecture)

  5. Hogervorst, E. Diagnosing dementia. International Psychogeriatrics meeting Novotel Jakarta July 2-5, 2008 (invited keynote)

  6. Hogervorst, E. Dental and other risk factors for dementia. Trisakti International Dentistry meeting Bumi Karsa Hotel Jakarta July 6-9 2008 (invited keynote lecture)

  7. Hogervorst E, Bandelow S. Diagnosis of early dementia Acta Neuropsychiatrica Conference Buenos Aires Argentina Invited keynote speaker Sept. 5-8 2007 (will also give separate talk on testosterone levels in dementia at this conference)

  8. Hogervorst, E. Testosterone and cognition in postmenopausal women. 18th meeting North American Menopause Society Invited keynote October 3-6 2007 Dallas Texas

  9. Hogervorst, E. Testosterone and well being in different cohorts. Invited paper as main speaker British Andropause Meeting RSM 28-30 March 2007 London

  10. Hogervorst E et al.. Dementia in Indonesia oral presentation at the International Dementia Conference Nairobi Africa, 10-13 April 2007

  11. Hogervorst, E. Androgens, genetic polymorphisms and Alzheimer’s disease. Alzheimer’s association meeting Madrid July 16-21 2006 (invited key note speaker)

  12. Hogervorst, E. TSH and cognitive function in elderly of MRC CFAS. BSRA meeting St Anne’s college 12th of July 2006 (invited key note speaker)

  13. Bandelow, S., Hogervorst, E., Combrinck, M, Smith A.D. Improving the diagnosis of early dementia using computerized validated systems. BSRA meeting St Anne’s college 12th of July 2006

  14. Hogervorst, E. Effects of testosterone and genetic variations relating to androgen metabolism on cognitive function in elderly men and women. The Aging Male 2006; 9 (1) March 2006 the World Conference on the Aging Male 2006 Feb 14-21, page 67 (poster)

  15. Hogervorst, E. Androgens and genetic variations in men with AD. Invited main speaker. The Aging Male 2006; 9 (1) March 2006 the World Conference on the Aging Male 2006 Feb 14-21, page 4.

  16. Hogervorst, E. Bandelow, S., Combrinck, M., Smith, A.D. Testosterone replacement may not be a good idea for everyone. Oral as main speaker and poster presentation Research Into Ageing/Help the Aged Grant holders conference Birmingham 5-6 September 2005

  17. Hogervorst. Differential Diagnoses of Dementia. Leicester Delivering the best 14 July 2005 (won best poster award £200,-)

  18. Hogervorst, E. CAG polymorphisms and Alzheimer’s disease in men. Testosterone and Androgens Society. Royal Society, London, 23-26 February 2005 (invited lecture as main speaker)

  19. Hogervorst, E. Diagnosis of early Alzheimer’s disease, MCI and VCI using cognitive tests. Anti-Ageing Conference, London, Sept 10-11, 2004 (invited paper as main speaker)

  20. Tri Budi W. Rahardjo *, Sudijanto Kamso *, Yudarini *, Subarkah*, Vita Priantina Dewi *, Philip Kreager ** and Eef Hogervorst Social Acivities and Possible Dementia among the Elderly in Rural and Urban Areas presented at the Geraitric Scientific Meeting in Jakarta 25–27 May 2007.

  21. E.S. Strotmeyer,1 F. Lauretani,2 E. Hogervorst,3 N. de Rekeneire,4 A.V. Schwartz,5 D.K. Houston, 6 J.S. Lee, 7 F.A. Tylavsky, 8 A.I. Vinik,9 K. Yaffe, 5 S. Kritchevsky, 6 S. Bandinelli,10 L. Ferrucci,11 T.B. Harris,11 A.B. Newman.1 Low vitamin B12 levels are related to worse peripheral nerve function in older adults. The GSA symposium, Peripheral Nerve Function and Its Associations in Aged Populations Friday Nov 17th 2006, Pitssburgh

  22. Henderson VW, Hogervorst E, Bandelow S. Mental activity, episodic memory, and mild cognitive impairment in a rural cohort. Neurology 62[suppl. 5]:A210, 2004.

  23. Hogervorst, E. Testosterone and vascular risk factors. 7th International symposium on Neurobiology and Neuroendocrinology of Aging July 18-23, 2004, Kloster Mehrerau, Bregenz, Austria (invited paper as main speaker)

  24. Hogervorst, E. Testosterone and Alzheimer’s disease. Prague, 2004 February 26-29. The World Conference for the Ageing Male Conference (invited paper as main speaker)

  25. Hogervorst, E. Levels of testosterone in women with AD. Washington DC March 17-20, 2004. Second world conference on Women’s mental health: cognitive aging and dementia (invited as main speaker)

  26. Schrijnemaeckers, A.M., Hogervorst, E., de Jager, C., Budge, M.M., Smith, A.D. MCI and procedural learning. VAS-Cog Gotheburg, Sweden, August 28-30 2003

  27. Van Os, L.A.H.M., Hogervorst, E., Combrinck, M., Smith, A.D. TSH and vascular risk factors for AD. VAS-Cog Gotheburg, Sweden, August 28-30 2003

  28. Hogervorst, E. HRT and cognitive function (invited lecture as main speaker). The 6th European Congres on Menopause (EMAS). Bucharest, Romania, 24-28 May, 2003

  29. Hogervorst, E. Combrinck, M. & Smith, A.D. Testosterone and Alzheimer's disease (invited paper as main speaker). Androgens Society. Royal Society, London, 31-1 January/February 2003

  30. Hogervorst, E. Combrinck, M. & Smith, A.D. TSH and AD. Alzheimer's Association meeting 20-25th July 2002, Stockholm

  31. Hogervorst, E. Lehman, D., McBroom, J. & Smith, A.D. Low levels of TT are associated with the APOE e4 genotype. Alzheimer's Association meeting 20-25th July 2002, Stockholm.

  32. Hogervorst, E. Combrinck, M., Dowsett, M, & Smith, A.D. Methodological and conceptual difficulties in assessing the association between sex hormone levels and Alzheimer’s disease The Graylyn Conference on Women’s Health. Poster Women’s cognitive Health, Graylyn International Conference Centre of Wake Forest University, Winston-Salem, North Carolina, Nov 8-10, 2001.

  33. Hogervorst, E. Serum homocysteine and gonadal hormone levels in the elderly. Poster 3rd International Homocysteine Conference Sorento July 1-5, 2001, 62.

  34. Hogervorst, E. Serum homocysteine, cerebrovascular risk factors and white matter low attenuation on CT in patients with Alzheimer’s disease. Poster 3rd Internat. Hcy Conf. Sorento July 1-5, 2001, 131.

  35. Hogervorst, E.. The nature of the effect of HRT on cognition in elderly women (invited lecture main speaker). British Pharmacological Society, Autumn meeting at the School of Pharmacy, Univ. of Bradford, 6-8 September, 2000, 12.

  36. Hogervorst, E., Barnetson, L., Dowsett, M., Smith, A.D. Women with Alzheimer’s disease have higher levels of estradiol than controls. Poster The 5th Annual Graylyn Conference on Women’s Health. The role of estrogen and other factors in dementia, Graylyn International Conference Centre of Wake Forest University, Winston-Salem, North Carolina, Nov 8-10, 1999, 4.

  37. Hogervorst, E., Boshuisen, M., Riedel, W., & Jolles, J. The effect of hormone replacement therapy on cognitive function in elderly women. International Society of Psychoneuro-endocrinology (ISPNE) XXIXth Annual Meeting. Europahalle Trier, Germany, Aug 02-06, 1998, 11-12.

  38. Hogervorst, E., Riedel, W.J., Schmitt, J.A.J., Houx, P.J., & Jolles, J. The effect of age, health, and speed of information processing on complex memory performance. Newsletter Dutch Psychological Association (NVP), December 1997; 12 (3), 33.

  39. Hogervorst, E., Riedel, W.J., van Boxtel, M.P.J., Visser, PJ, Hameleers, P., Seij S, Jolles,J. Hypoxia and hyperventilation as models for cognitive deficiencies. European NeuropsychoPharmacology, June 1996; 6 (S3), 145.

  40. Riedel. W., Hogervorst, E., Verhey, F., Jolles, J. Scopolamine is a model of memory dysfunction not of aging. European Neuropsychopharmacology, June 1996; 6 (S3), 144.

  41. Hogervorst, E., Riedel, W.J., van Boxtel, M.P.J., Jolles, J. Hypoxia and hyperventilation as models forcognitive defiencies. European Neuropsychopharm., Sept 1996; 6 (S4), 166.

  42. Riedel, W.J., Hogervorst, E., & Jolles, J. Cognitive enhancers and human aging. European Neuroscience Annual Meeting. Amsterdam, 3-7 September 1995.

  43. Riedel, W., Leboux, R.L.M., Hogervorst, E., Quist, A., Van der Vusse, A., Verhey, F.R.J., & Jolles, J..Caffeine enhances memory function after cholinergic blockade. Neurobiology of Aging, 1994, 15 (1), S100-101.

 

Scientific publications in national journals

  1. Hogervorst, E., Budge, M., & Barnetson L. (1999). Sex hormones and Alzheimer’s disease. Alzheimer’s Research Trust Newsletter, Spring/Summer edition, 3-4.

  2. Merckelbach, H., Hogervorst, E., Kampman, M., & De Jongh, A. (1994). 'Eye-movement desensitisation' heeft geen effect op de emotionele reactiviteit van 'normale proefpersonen. ('Eye-movement desensitisation' does not affect the emotional reactivity of 'normal' subjects). Gedragstherapie, 27 (1), 33-49

  3. Merckelbach, H., Hogervorst, E., & Kampman, M. (1993). Geen ondermijnend effect van 'Eye-movement desensitisation ' op het visueel geheugen (No detrimental effect of 'Eye movement desensitisation' on visual memory). Directieve Therapy, jaargang 13 November. Bohn Stafleu Van Loghum.

 

Book sections

  1. Yesufu, A., Bandelow, S, Rahardjo, T, Hogervorst, E. Dementia diagnoses. Nova sciences

  2. Clifford, C., Bandelow,. S, Hogervorst, E. Exercise and Cognition. Nova Sciences

  3. Hogervorst, Bandelow & Talbot. Chapter 15 in Hormones, Cognition and Dementia, commissioned by Cambridge University Press Eds. Hogervorst, E., Henderson, V, Gibbs, B, Brinton-Diaz, R, pp.

  4. Hogervorst, Bandelow & Lehmann. Chapter 18 in Hormones, Cognition and Dementia, commissioned by Cambridge University Press Eds. Hogervorst, E., Henderson, V, Gibbs, B, Brinton-Diaz, R, pp.

  5. Hogervorst, E. Tempe is associated with less risk for dementia. Chapter 13 in Hormones, Cognition and Dementia, commissioned by Cambridge University Press Eds. Hogervorst, E., Henderson, V, Gibbs, B, Brinton-Diaz, R

  6. Rahardjo TRW, Hartono, T, Priatina, VD, Hogervorst,. E Arifin, EN 2009 Chapter 10. Facing the geriatric wave in Indonesia: Financial Conditions and Social Support. In Arifin EN, Ananta A. (eds) Older Persons in Southeast Asia: an emerging asset. Publisher: Institute of Southeast Asian Studies: Singapore, pop.

  7. Bandelow S, Hogervorst E. (2008). invited paper. Testosterone or gonadotropin lowering treatment for Alzheimer's Disease: predicting risk or benefit. Eds: Raymund E. Veritos, in: Trends in Testosterone Research, Nova Science Publishers, pp.61-69

  8. Bandelow S, Hogervorst E. (2007). Testosterone levels and testosterone treatment for men with Alzheimer’s disease. (in press) Nova Publishers

  9. Hogervorst, E. The short-lived effect of HRT on cognition function (2006) Invited review. In: Rasgon NL (ed). The Effects of Estrogen on Brain Function. John Hopkins Press. Baltimore, MD 46-78

  10. Yesufu, A, Bandelow, S., Hogervorst, E. (2006 invited review) The role of sex steroids in Alzheimer’s disease and age-related cognitive decline. In Sun M-K (ed) ‘Research Progress in Alzheimer's Disease and Dementia’ vol 2, chapter X Nova Publishers

  11. Riedel, W.J., Hogervorst, E., Verhey, F.R.J., & Jolles, J. (1997). Measuring Cognitive Abilities in Cholinergic Dysfunction. In: I. Hindmarch. & P.D. Stonier (Eds). Human Psychopharmacology: Measures and Methods; Vol VI. Chichester: Wiley, 29-56.

  12. Hogervorst, E., Riedel, W.J., Rozendaal, N., van Boxtel, M.P.J., & Jolles, J. (1995). Smoking and cognitive complaints. In: J. Jolles, P.J. Houx, M.P.J. van Boxtel, & R.W.H.M. Ponds (Eds). The Maastricht Aging Study: Determinants of cognitive aging. Maastricht, the Netherlands: Neuropsych Publishers, 105-110.

  13. Riedel, W.J., Hogervorst, E., & Jolles, J. (1995). Cognition enhancers and aging. In:J. Jolles, P.J. Houx, M.P.J. van Boxtel, & R.W.H.M. Ponds (Eds). The Maastricht Aging Study: Determinants of cognitive aging. Maastricht, the Netherlands: Neuropsych Publishers, 149-156.

  14. Riedel, W. J., Leboux, R. L. A. M., Hogervorst, E., Quist, A., Vusse, A. v. d., Verhey, F. R. J., & Jolles, J. (1994). Caffeine and Nicotine selectively enhance Memory and Attention after Cholinergic Blockade. In W. van Tilburg (Ed.). The Borderland Between Normal and Pathological Aging. Amsterdam, The Netherlands: International Psychogeriatric Association, 47.

 

Reports / Proceedings

  1. Hogervorst, E. Gleeson, M, Oliveira, M, Bandelow S & Schmitt JAJ. Caffeine, cognition and sports performance. Final Acticaf Report Nestle , May 5, 2007

  2. Hogervorst, E. Alzheimer’s disease prevalence and QALY. Solvay pharmaceuticals December 2004

  3. Hogervorst, E. & de Jager, C., Cognitive tests to assess estrogenic effects. Report Phytopharm November 2002

  4. Hogervorst, E. & de Jager, C., Research proposals for J&J: OPTIMA and Challenge, August 2002

  5. Hogervorst, E. & Budge M. Specificity of the Hopkins Verbal Learning Test. Proposal for Bristol- Meyers-Squibb, September 1999 (report January 2001)

  6. Hogervorst, E. & Budge, M. Outline for cognitive testing in the RUTH Study. Proposal for Evista-Lily April 1999

  7. Hogervorst, E., Barnetson, L., Budge, M., Combrinck, M., & Smith, A.D. Total serum testosterone in Alzheimer’s disease. 16th interim Report for Bristol Meyers Squibb June 1999

  8. Hogervorst, E., Riedel, W.J., van Boxtel, M.P.J., & Jolles, J. Estrogen Replacement Therapy and cognitive functioning in healthy, elderly women. Report for Organon. June 1996

  9. Hogervorst, E., Riedel, W.J., Kovacs, E., Brouns, F., & Jolles, J. The effect of caffeine and strenuous exercise on cognitive performance. Report for Sandoz Nutrition. Dec 1996.

 

Conference papers

  1. Bandelow, S, Hogervorst, E, Smith AD. The development of computational tools for dementia diagnosis International Conference on Advanced Computational Intelligence and Its Applications 2008 Jakarta Indonesia (1st - 2nd September)

  2. Hogervorst, E. et al. Ageing and Dementia. Conference paper University of Indonesia, Depok Seminar day on ageing, gender and health 27 Feb 2008

  3. Rahardjo TRB, Hartono, T, Priatina, D, Hogervorst,. E 2007 Financial Condition and Support for Indonesia Older People: international workshop on Financing Issues for an Ageing Society in Southeast Asia 3-5 September 2007 Institute of Southeast Asian Studies Singapore

  4. Budge, M., Johnston, C., Hogervorst, E., De Jaeger, E., Milwain, S., Iversen, S., Barnetson, L., King, E., & Smith, A.D. Plasma total homocysteine levels and cognitive performance in a normal elderly population. Vascular factors in Alzheimer’s disease. Newcastle-upon-Tyne, May 25-28, 1999.

  5. Hogervorst, E. Modellen voor cognitieve dysfuncties (Models for cognitive dysfunction). Symposium-bundel VBGGK 'Onderzoek onder de loep'- Maastricht, Feb. 9 1995.

  6. Hogervorst, E. Oestrogenen en postmenopausale vrouwen (Estrogen and postmenopausal women); De behandeling van ouderdomsgerelateerde klachten (Treatment of age-related cognitive dysfunction); Mentaal functioneren en veroudering (Mental functioning and ageing). Symposium 'Een Vrolijke Oude Dag' Amsterdam, April 1-2 1995.

 

Lectures, talks and poster presentations

  1. Hogervorst, E. Sex steroids and cognition: age matters. Bioknex special interest meeting on the Ageing Brain , 25 March 2008, Prestwold Hall Loughborough

  2. Bandelow, S and Hogervorst, E. Diagnosing dementia using computerized tests. Bioknex special interest meeting on the Ageing Brain , 25 March 2008, Prestwold Hall Loughborough

  3. Hogervorst, E. Sex steroid hormones and cognition in men and women (invited lecture at Karolinska Institute Stockholm Sweden (2 lectures) 28 February 2009

  4. Hogervorst, E. Testosterone and cognition. Testosterone and men's health 1 Nov 2008 Royal College of Physicians Dublin, Ireland

  5. Hogervorst E. Can I prevent dementia. ART Public Awareness Lecture University of Leicester 15 Sept 2008

  6. Hogervorst E. Risk factors for dementia. Invited lecture Medical faculty UPH Jakarta Indonesia 21 Augustus 2008

  7. Hogervorst, E. Successful scientific writing workshop. Department of Public Health UI Depok Indonesia 28 Augustus 2008

  8. Hogervorst, E. Workshop Research methodology and statistics. Bali Indonesia 14-17 augustus 2008

  9. Hogervorst E. Ageing and Dementia University of Indonesia, Depok February 27 2008

  10. Hogervorst E. Invited lecture Neuroscience interest group 21 May 2008, East Midlands Airport UK

  11. Hogervorst E. Mental activity and dementia. Invited lecture for Council/John Storer House Loughborough 8-4-2008

  12. Hogervorst, E. Ageing in Indoneisa. Invited keynote presentation at Oxford Institute of Ageing 31 Jan 2008

  13. Hogervorst E Tofu and dementia. ART meeting June 2008 Birmingham

  14. Hogervorst E, Bandelow S, Gleeson M Acticaf: effects on physical and mental performance. Invited lecture Nestle Lausanne 18-21 June 2007

  15. vd Wardt V Bandelow S, Black K, Hogervorst E. Classification systems for athletes with learning disability. Expert meeting INAS, PIC for Paralympics 2012 Leuven June 5-6 2007

  16. Hogervorst E. Dementia and phytoestrogen levels in Indonesia. Yogjakarta and Jakarta, University of Respati Public Health and University of Indonesia, Center for Health January 20-28 2007

  17. Hogervorst E, Bandelow S, Gleeson M Acticaf: effects on physical and mental performance. Invited lecture Nestle Lausanne 18-21 June 2007

  18. vd Wardt V Bandelow S, Black K, Hogervorst E. Classification systems for athletes with learning disability. Expert meeting INAS, PIC for Paralympics 2012 Leuven June 5-6 2007

  19. Hogervorst E. Dementia and phytoestrogen levels in Indonesia. Yogjakarta and Jakarta, University of Respati Public Health and University of Indonesia, Center for Health January 20-28 2007

  20. Hogervorst, E. TSH and cognitive function in the Healthy Ageing cohort MRC CFAS group meeting September 2006

  21. Hogervorst, E. Testosterone and genetic polymorphisms (invited keynote speaker) Alzheimer’s association meeting Madrid July 16-21 2006

  22. Hogervorst, E. Effects of testosterone and genetic variations relating to androgen metabolism on cognitive function in elderly men and women. The Aging Male 2006; 9 (1) March 2006 the World Conference on the Aging Male 2006 Feb 14-21, page 67 (poster)

  23. Hogervorst, E. Androgens and genetic variations in men with AD. Invited main speaker. The Aging Male 2006; 9 (1) March 2006 the World Conference on the Aging Male 2006 Feb 14-21, page 4.

  24. Hogervorst, E. Testosterone and genetic polymorphisms in AD. Invited lecture and poster Research Into Ageing. Birmingham 4 September 2005

  25. Hogervorst, E. Phytoestrogens as an alternative for HRT. Invited lecture Nestle Lausanne, 2006

  26. Hogervorst, E. Drugs and the Brain. Invited lecture for adolescents. Loughborough University 4 July 2005

  27. Hogervorst, E. CAG polymorphism and AD. Invited lecture as main speaker for the 5th conference for the Society for the study of androgen deficiency in the adult male, 24 February 2005 Royal Society London

  28. Hogervorst, E. HRT and Cognitive Function: biological aspects. Invited Departmental Lecture Psychology University of Leeds; 16 February 2005

  29. Hogervorst, E. Diagnosis of early Alzheimer’s disease, MCI and VCI using cognitive tests. Anti-Ageing Conference, London, Sept 10-11, 2004 (invited paper as main speaker)

  30. Hogervorst, E. Nutritional aspects of cerebrovascular disease and dementia, Invited lecture course Nutritional Medicine, University of Surrey, Guildford, 16-7-2004

  31. Hogervorst, E. The history of the paradigm shift of HRT. McCurdy lecture June 9th, 2004 Addenbrookes hospital Cambridge (invited lecture)

  32. Hogervorst, E. Testosterone and vascular risk factors. Experimental Gerontology Meeting. Bregrenz, Austria, July (invited paper as keynote speaker)

  33. Hogervorst, E. Testosterone and Alzheimer’s disease. Prague, 2004 February 26-29. The World Conference for the Ageing Male Conference (invited paper as speaker)

  34. Hogervorst, E. Levels of testosterone in women with AD. Washington DC March 17-20, 2004. Women’s mental health: cognitive aging and dementia (invited paper as speaker)

  35. Hogervorst, E. HRT and cognitive function. Invited as consultant for the WHIMS Scientific Committee Advisory board for Wyett Pharmaceuticals, Philadelphia Airport Marriott, USA, March 17, 2003

  36. Hogervorst, E. Androgen deficiency in men with AD. Invited lecture as main speaker for the 3rd conference for the Society for the study of androgen deficiency in the adult male, 31th January 2003 Royal Society London

  37. Hogervorst, E. Diagnosing dementia. Invited lecture Clinical Neuropsychology Witts Theater Radcliffe Infirmary, 24 January 2003

  38. Hogervorst, E. Difficulties in diagnosing dementia. Invited lecture Somerville College Oxford, 24 January 2002; in OPTIMA May 2002

  39. Hogervorst, E. Geheugenprestatie bij gezonde en pathologische veroudering. Invited lecture Instituutsdag Hersenen en Gedrag 18 January 2002, University of Maastricht

  40. Hogervorst, E. The early diagnosis of dementia. Invited lecture Linacre College, 20 November 2001

  41. Hogervorst, E., DeJager, C. The diagnostic value of the HVLT. Lecture PSIGNE, Keble College, 3rd July 2001

  42. Hogervorst, E. Diagnosing dementia. Invited lecture (by Professor Pat Rabbit). University of Manchester, Department of Psychology, 19th of June, 2001

  43. Hogervorst, E. The Hopkins Verbal Learning Test and screening for dementia. Poster 3rd Memory Clinic Conference 5th of June 2001, Reading

  44. Hogervorst, E. Hormones and cognitive function: does sex matter ? Invited lecture for the Challenge Cohort, Radcliffe Infirmary, Jan 24, 2001

  45. Hogervorst, E. Hormones, memory decline and Alzheimer’s disease. Interview on BBC4 with Jenny McMurray on World Alzheimer’s Day, September 21, 2000

  46. Hogervorst, E., Budge, M., Williams, J., Smith, A.D. The effects of HRT on cognition in elderly women. Invited key lecture in Symposium ‘Memory and Cognition Enhancement in the Aged’ at the University of Bradford, British Pharmacological Society Autumn meeting, Bradford, U.K., September 7, 2000

  47. Hogervorst, E., Boshuisen, M., Riedel, W., & Jolles, J. Hormones and cognitive function and mood. in elderly women. Invited lecture at Duke Medical Centre, Durham, North Carolina, U.S.A., Nov. 5, 1999.

  48. Hogervorst, E., Boshuisen, M., Riedel, W., & Jolles, J. The effect of hormones on cognition. Invited lecture at Churchill hospital, Oxford, England, June 9, 1999.

  49. Hogervorst, E., Barnetson, L., Budge, M., Combrinck, M., & Smith, A.D. Total serum testosterone in Alzheimer’s disease. 16th interim Report for Bristol Meyers Squibb, Depart. of Pharmacology, Oxford, England, June 6, 1999

  50. Hogervorst, E.. Hormones and cognitive function. Invited seminar Linacre College, Oxford, May 11, 1999

  51. Hogervorst, E.. Testosterone levels in Alzheimer’s disease. OPTIMA group meeting, Radcliffe Infirmary, Oxford, England, March 31, 1999

  52. Hogervorst, E., Boshuisen, M., Riedel, W., & Jolles, J. The effect of hormones on cognitive function in elderly women. Invited lecture at the 1996 Annual Meeting of the Psychobiology Section of the British Psychology Society, The Old Dungeon Ghyll Hotel, Cumbria, England, September 16-18 1998

  53. Hogervorst, E., Boshuisen, M., Riedel, W., & Jolles, J. The effect of hormone replacement therapy on cognitive function in elderly women. Award winning lecture and oral presentation at the 19th International Society of Psychoneuroendocrinology Annual Meeting. Europahalle Trier, Germany, Aug 2-6 1998.

  54. Hogervorst, E.. Gonadal hormones and cognitive function in elderly women. Invited lecture at University of Oxford, Radcliffe Infirmary Trust, Oxford, July 9 1998

  55. Hogervorst, E. The effect of age, health, and speed of information processing on complex memory

  56. performance. Paper presented at the 6th Winterconference ‘Nederlandse Vereniging voor Psychonomie’ (Dutch Society for Psychonomics), Egmond aan Zee, December 19-20 1997.

  57. Hogervorst, E., Riedel, W., & Jolles, J.. Models of cognitive ageing. Oral presentation at the Symposium on Brain, Cognition, and Behaviour, Maastricht, November 29 1996

  58. Hogervorst, E., Riedel, W.J., van Boxtel, M.P.J., Jolles, J. Hypoxia and hyperventilation as models for cognitive deficiencies. Poster presentation at the 9th Congress of the European College of Neuropharmacology, Amsterdam, September 21-25 1996.

  59. Hogervorst, E., Riedel, W.J., van Boxtel, M.P.J., & Jolles, J. Hypoxia and hyperventilation as models for cognitive deficiencies. Invited lecture at the 1996 Annual Meeting of the Psychobiology Section of the British Psychology Society, The Old Dungeon Ghyll Hotel, Cumbria, England, September 18-20 1996

  60. Hogervorst, E., Riedel, W.J., van Boxtel, M.P.J., Visser, P-J, Hameleers, P., & Seij S. Hypoxia and hyperventilation as models for cognitive deficiencies. Oral presentation at the xxth Collegium Internationale NeuroPsychopharmacologicum Congress, Melbourne, Australia, June 23-27 1996.

  61. Hogervorst, E. Modellen voor cognitieve dysfuncties (Models for cognitive dysfunction). Symposium VBGGK 'Onderzoek onder de loep' Maastricht, Feb. 9 1995.

  62. Hogervorst, E. Cognitive models of ageing. Oral presentation Dutch Scientific Organisation (NWO) section 'Gerontology and Geriatrics' Driebergen, the Netherlands, June 6-7 1994.

  63. Hogervorst, E. Experimental psychological studies of 'Eye-movement desensitisation and reprocessing'. Oral presentation VGT Conference, Dalfsen, the Netherlands, November 4-5 1993.

 

ACR Home | Our Research | Selected Publications
People in the Group | News | Contact Us
See also: Centre for Global Health & Human Development

SSEHS search

Why Loughborough?